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Background: Hypovitaminosis D is associated to accentuated bone loss. However, association between
osteoporotic vertebral fractures (VFs) and vitamin D status has not been clearly established.
Objective: To determine serum vitamin D status and to assess the association of vitamin D status with bone
mineral density (BMD) and asymptomatic VFs prevalence using vertebral fracture assessment (VFA) in a cohort of
Moroccan menopausal women.
Methods: from June to September 2010, 178 menopausal women 50 years old and over were enrolled in this
cross-sectional study. The mean ± SD (range) age, weight, height and BMI were 58.8 ± 8.2 (50 to 79) years,
73.2 ± 13.8 (35 to 119) Kgs, 1.56 ± 0.06 (1.43 – 1.79) m and 29.8 ± 5.9 (17.5 – 49.8) kg/m2, respectively. VFA images and
scans of the lumbar spine and proximal femur were obtained using a GE Healthcare Lunar Prodigy
densitometer. VFs were defined using a combination of Genant semiquantitative approach and morphometry.
Serum levels of 25-hydroxyvitamin D (25(OH)D) were measured.
Results: Among the 178 women, 45 (25.2%) had densitometric osteoporosis, and on VFA, VFs (grade 2 or 3) were
detected in 20.2% while grade 1 were identified in 33.1%. The mean values of serum levels of 25(OH)D were
15.8 ± 11.6 ng/ml (range: 3.0 – 49.1) with 152 patients (85.3%) having levels <30 ng/ml (insufficiency) and 92
(51.6%) <10 ng/ml (deficiency). Stepwise regression analysis showed that presence of VFs was independently
related to age, 25(OH)D and densitometric osteoporosis.
Conclusion: our study shows that advanced age, hypovitaminosis D and osteoporosis are independent risk
factors for asymptomatic VFs in Moroccan postmenopausal women.
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Osteoporosis and low-trauma fractures in elderly people
are a substantial and increasing burden of ill health
worldwide and the rates of hip and other fractures are
rapidly increasing in developing countries [1]. Vitamin D
status has for long been recognized as an important factor
for bone health and its contribution to fracture risk has
recently received increased attention. It is demonstrated
that hypovitaminosis D is associated to accentuated bone* Correspondence: aelmaghraoui@gmail.com
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distribution, and reproduction in any mediumloss, leading to an increased risk of osteoporotic fractures.
Moreover, new data suggest that its benefits extend beyond
healthy bones [2,3].
Direct sunlight stimulates the production of vitamin D
in the skin from 7-dehydrocholesterol. Other sources of
vitamin D include some natural foods (e.g., fatty fish),
fortified foods (e.g., margarine), and supplements. The
amount of vitamin D produced through exposure to
UVB radiation depends on skin type: the darker the
skin, the more sunlight is required to produce a given
amount of vitamin D. The duration of UVB irradiation
needed to produce a certain quantity of vitamin D in a
particular skin surface depends on season, time of day,entral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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lower the UVB intensity, and the fewer months and
hours per day during which vitamin D is produced.
Vitamin D insufficiency remains an under recognized
problem in adults in the world [4]. In the United States,
national population statistics from the 3 rd National
Health and Nutrition Examination Survey (NHANES III)
indicate that 41% of men and 53% of women have hypo-
vitaminosis D [5]. Paradoxically, many recent studies
have shown a high prevalence of vitamin D deficiency in
many tropical and sunny countries such as Turkey [6],
India [7], Iran [8], United Arab Emirates [9] and Saudi
Arabia [10]. In Morocco, where sunlight is abundant,
throughout the year, one study showed that during the
summer season, vitamin D insufficiency is very common
in healthy adult Moroccan women (91%) [11]. In this
study, lack of sun exposure and veiled clothing style were
the most important factors that influenced vitamin D
status.
Many studies linked hypovitaminosis D and hip frac-
tures. However, association between osteoporotic verte-
bral fractures (VFs) and vitamin D status has not been
clearly established. In contrast to hip fractures, the ma-
jority of VFs are asymptomatic. Worldwide, underdiag-
nosis of VFs is a major problem. Additionally, studies
have demonstrated that prevalent VFs can predict future
VFs [12], hip fracture [13], and increased mortality dur-
ing the following decade [14,15].
X-rays are the gold standard for identifying VFs. How-
ever, recent studies showed that vertebral fracture assess-
ment (VFA) using dual-energy X-ray absorptiometry
(DXA) machines has demonstrated great utility for verte-
bral visualization [16-18]. The combination of low radi-
ation exposure, low cost, high technical reproducibility
and easy data storage renders the method attractive pro-
viding a rapid and convenient way for clinicians to iden-
tify patients with VFs [19].
In view of limited data on vitamin D status and its as-
sociation with bone mineral density (BMD) or VFs risk
in Moroccan women, the objectives of this study were to
determine serum vitamin D status and to assess the asso-
ciation of vitamin D status with BMD and asymptomatic
VFs prevalence using VFA.
Methods
Subjects
This was a cross-sectional study conducted from June
2010 to September 2010 with menopausal women
50 years old and over, living in the region of Rabat,
recrutized from the general population through adver-
tisements and “word of mouth” in local hospitals. The
city of Rabat is located on the western side of Morocco
(latitude 34° and longitude 6°). Rabat is the capital of
Morocco with a diverse population representing mostMoroccans. Morocco has a population of 32,148,716 (es-
timation from the 2004 population Census), most of
whom are Caucasians, and Rabat is a modern city of 620
996 inhabitants (51.6% female).
One hundred and seventy eight consecutive women
who had no previous diagnosis of osteoporosis were
entered into the study. General exclusion criteria were
non-Caucasian origin and diseases, drugs, and other
major determinants known to affect bone metabolism.
Thus, we excluded subjects with gastrectomy, intestinal
resection, recent thyroid dysfunction or hyperparathyr-
oidism, recent severe immobilization or treatment with
corticosteroids (more than 3 months) or any medication
interfering with bone metabolism. Our institutional
review board approved this study. The procedures of
the study were in accordance with the Declaration of
Helsinki, and formal ethics committee approval was
obtained for the study. All the participants gave an
informed and written consent. Each subject completed
a standardized questionnaire designed to document
putative risk factors of osteoporosis. History of frac-
tures, lifestyle (alcohol consumption, gymnastics or
jogging/walking, smoking) and diet (milk, yogurt,
cheese) habits were also recorded. The women were
asked whether they usually drank milk, coffee, or al-
cohol, if they ate cheese or yogurt, if they did gym-
nastics or jogging/walking, and if they smoked
tobacco. Menstrual and reproductive history were
assessed: all patients were menopausal since at least
one year. Height and weight were measured in our
centre before DXA measurement, in light indoor
clothes without shoes. Body mass index (BMI)] was
calculated by dividing weight in kilograms by height
in meters squared.
BMD measurement
Bone mineral density was determined by a Lunar Prodigy
Vision DXA system (Lunar Corp., Madison, WI). The
DXA scans were obtained by standard procedures sup-
plied by the manufacturer for scanning and analysis. All
BMD measurements were carried out by 2 experienced
technicians. Daily quality control was carried out by
measurement of a Lunar phantom. At the time of the
study, phantom measurements showed stable results.
The phantom precision expressed as the coefficient of
variation percentage was 0.08. Moreover, reproducibility
has been assessed in clinical practice and showed a smal-
lest detectable difference of 0.04 g/cm2 (spine) and 0.02
(hips) [20,21]. Patient BMD was measured at the lumbar
spine (anteroposterior projection at L1-L4) and at the fe-
murs (i.e., femoral neck, trochanter, and total hip). The
World Health Organization (WHO) classification system
was applied, defining osteoporosis as T-score ≤−2.5 and
osteopenia as −2.5<T-score<−1. Study participants
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bar spine, femur neck, or total femur.
VFA was classified using a combination of Genant
semiquantitative (SQ) approach and morphometry in the
following manner: each VFA image was inspected visu-
ally by two clinicians (IG and AR who had a previous
training session in VFA) to decide whether it contained a
fracture in any of the visualized vertebrae. Each vertebra
that was judged as fractured by visual inspection by any
of the investigators was measured using built-in morph-
ometry and assigned a grade based on Genant SQ scale
[22], where grade 1 (mild) fracture is a reduction in ver-
tebral height of 20-25%, grade 2 (moderate) a reduction
of 26-40%, and grade 3 (severe) a reduction of over 40%.Laboratory evaluation
All blood samples were collected under fasting condi-
tions on the same day of acquisition of the VFA images
from June 2010 to September 2010 (a sunny period), be-
tween 8 and 10 a.m., stored at −20°C, and analyzed at
the same time. The serum concentrations of calcium
(adjusted for the albumin concentration), phosphorus, al-
kaline phosphatase, and creatinine were determined
according to automated standard laboratory methods.
The serum concentration of 25-hydroxivitamin D (25
(OH)D) was measured using electrochimiluminescence
on ELECSYS 2010 analyser (Roche Diagnostics, Mann-
heim).The intra and inter-assay variation coefficients in
our laboratory were 10.5% and 17.8%, respectively. In the
present study, 25(OH)D values of≤ 30 ng/ml were
defined as vitamin D insufficiency and of ≤ 10 ng/ml as
vitamin D deficiency. When comparing to other studies
in the literature, serum 25(OH)D concentrations pre-
sented in nanomole per liter or microgram per liter were
transformed into nanogram per milliliter.Table 1 Characteristics of the population study (n = 178)
Mean±SD Range
Age (years) 58.8 ± 8.2 50–79
Weight (Kg) 73.2 ± 13.5 35–158
Height (m) 1.56 ± 0.06 1.43–1.79
BMI (Kg/m²) 30.0 ± 5.5 14.5–50.8
Number of parity 5.4 ± 2.6 0–13
Years since menopause 10.9 ± 9.5 1–30
BMD lumbar spine (g/cm²) 0.984 ± 0.1 0.550–1.410
BMD total hip (g/cm²) 0.870 ± 0.1 0.310–1.283
T-score lumbar spine (SD) −1.3 ± 1.3 −4.9–2.1
T-score total hip (SD) −1.2 ± 1.2 −4.7–2.1
25OH vitamin D (ng/ml) 15.8 ± 11.6 3.0–49.1Statistical analysis
Results are presented as means (SD) and categorical vari-
ables are expressed as frequencies. To compare patients
with and without VFs, chi-square test and ANOVA were
used firstly. Potential risk factors were entered to a step-
wise conditional binary regression analysis and the
resulted odds ratios with 95% confidence intervals
were reported. Logistic-regression models were used
to analyze the most important factors related to the
presence of moderate/severe VFs. Only the variables
significantly (p< 0.05) associated with moderate/severe
VFs in the univariate analysis were included in the
final logistic-regression. Because the colinearity between
BMD sites, one after another was put in logistic-regression
and the best model was selected. Hosmer and Lemeshow
test were used to adjust the logistic-regression models.The level for significance was taken as p ≤ 0.05. Excel
2007 and SPSS 15.0 were used for statistical analysis.Results
In this cohort of 178 women, the mean± SD (range) age,
weight and BMI were 58.8 ± 8.2 (50 to 79) years,
73.2 ± 13.8 (35 to 119) Kgs and 29.8 ± 5.9 (17.5 – 49.8)
kg/m2, respectively (Table 1). Thirty six women (20.2%)
had a history of traumatic peripheral fracture in younger
age (radius = 19, tibia = 16, femur = 1). The prevalence of
osteoporosis (any site) was 25.2% (n = 45).
In these 178 women, 74% of vertebrae from T4–L4
and 82% from T8–L4 were adequately visualized on
VFA. The percentage of vertebrae not visualized at T4,
T5, and T6 levels was 72.6%, 56.6, and 35.4% respect-
ively. Vertebral fractures (grade 2 or 3) were detected in
20.2% (36/178) of these women while grade 1 were iden-
tified in 33.1% (59/178). Fractures were most common
in the mid-thoracic spine and at the thoraco-lumbar
junction.
The serum concentrations of calcium (adjusted for the
albumin concentration), phosphorus, alkaline phosphatase,
and creatinine were within normal range. Serum levels of
25(OH)D distribution according to age is represented in
Figure 1. The mean values were 15.8±11.6 ng/ml (range:
3.0 –49.1). Globally, 152 patients (85.3%) had levels
<30 ng/ml (which defined vitamin D insufficiency), 117
(65.7%) had levels< 20 ng/ml, and 92 (51.6%) had levels
<10 ng/ml (which defined vitamin D deficiency).
As would be expected, the prevalence of VFA-detected
fractures globally increased with age and as BMD
declined. Comparison between patients without VFs and
with grade 1 or grade 2/3 VFs showed that the latter
were significantly older, lighter and had lower BMD and
lower values of 25(OH)D in a significant linear associ-
ation (Table 2). A significant linear association was also
found between the severity of VFs and the prevalence of
Figure 1 Vitamin D distribution in our population study (n = 178).
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were vitamin D insufficient compared to 85% of patients
with grade 1 VFs and 78% of patients without VFs.
Comparison between patients according to vitamin D





Age (years) : m (SD) 54.5 (5.7)
Weight (Kg) : m (SD) 74.6 (12.6)
Height (m) : m (SD) 157.6 (5.9)
BMI (Kg/m²): m (SD) 30.1 (5.7)
History of fracture: n (%) 14 (17.3)
Menopause duration (years) : m (SD) 6.8 (5.6)
Number of parities: m (SD) 4.3 (2.3)
Vitamin D (ng/l) : m (SD) 18.7 (12.8)
Vitamin D insufficiency: n(%) 63 (77.8)
Total hip BMD (g/cm²): m (SD) 0.910 (0.17)
T-score total hip (SD) : m (SD) −0.8 (1.2)
Lumbar spine BMD (g/cm²): m (SD) 1.131 (0.19)
T-score lumbar spine (SD) : m (SD) −1.1 (1.2)insufficiency or deficiency had lower lumbar spine and
hip T-scores and more prevalent VFs.
Stepwise logistic regression analysis for the presence of
grade 2/3 VFs (grade 1 VFs were excluded from this ana-





grade 2 and 3 VFs
N=35
p
60.6 (7.9) 66.0 (7.7) 0.0001
76.2 (14.5) 68.2 (12.3) 0.017
156.3 (5.9) 155.1 (6.3) NS
31.1 (5.4) 28.3 (5.0) NS
12 (19.4) 9 (25.7) NS
12.1 (9.0) 18.4 (10.7) 0.0001
5.3 (2.1) 5.8 (2.8) 0.005
17.5 (9.7) 6.2 (7.2) 0.0001
56 (90.3) 35 (100) 0.001
0.792 (0.12) 0.786 (0.11) 0.001
−1.3 (1.2) −1.9 (0.9) 0.0001
0.980 (0.15) 0.912 (0.10) 0.007
−1.4 (1.2) −1.9 (0.8) 0.006












Age (years): m(SD) 58.5 (6.7) 58.1 (6.9) 59.4 (9.1) NS
Weight (Kgs): m(SD) 78.7 (16.3) 71.9 (13.1) 73.8 (12.8) NS
Lumbar spine BMD (g/cm2): m(SD) 1.030 (0.16) 0.956 (0.16) 0.982 (0.15) NS
Total hip BMD (g/cm2): m(SD) 0.998 (0.18) 0.854 (0.14) 0.841 (0.14) NS
Lumbar spine T-score: m(SD) −0.8 (1.4) −1.5 (1.2) −1.3 (1.2) 0.0001
Total hip T-score : m(SD) −0.2 (1.5) −1.3 (1.1) −1.4 (1.1) 0.0001
Prevalence of osteoporosis: n(%) 4 (16.0) 15 (25.0) 26 (28.3) NS
Prevalence of VFs: n(%) 5 (20.0) 36 (60.0) 53 (57.6) 0.002
Prevalence of grade 2/3 VFs: n(%) 1 (4.0) 6 (10.0) 28 (30.4) 0.0001
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any site (lumbar spine, femoral neck and/or total hip). It
showed that presence of grade 2/3 VFs was independently
related to age, serum levels of 25(OH)D and the presence
of osteoporosis (Table 4). When patients with grade 1 VFs
(VFs yes/no) were included in the analysis, the results were
almost identical (data not shown).Discussion
We analyzed in this study the associations between serum
25(OH)D levels, BMD, and prevalence of VFs in a popula-
tion of asymptomatic postmenopausal women. Our study
demonstrated that increasing age, osteoporosis and hypo-
vitaminosis D were the most important independent fac-
tors associated to the presence of prevalent VFs.
In agreement with our results, Gerdhem et al. evaluated
986 women and determined that patients with vitamin D
levels below 20 ng/ml (50 nmol/L) had a twofold increased
risk of presenting any type of osteoporotic fractures com-
pared to women with levels above this value [23]. However,
only symptomatic osteoporotic fractures were assessed in
this study and it is well known that the majority of VFs is
actually asymptomatic and mostly undiagnosed [24]. More
recently and as shown in our study, Lopes et al. [25]. found
similar results: vitamin D insufficiency, age, and femoral
neck BMD were the most important factors for prevalent
moderate/severe vertebral fractures in a series of 415 eldery
Brazilian women assessed with VFA.Table 4 Multiple logistic regression analysis for the
presence of grade 2/3 vertebral fractures
Exp (B)[95% CI] p
Age 1.303 [1.148–1.480] <0.0001
25 OH Vitamin D 0.692 [0.525–0.913] <0.0001
T-score≤−2.5 (any site) 4.860 [1.078–21.917] 0.04Evaluation of the relationship between 25(OH)D and hip
fractures by several investigators has shown that low serum
levels of serum 25(OH)D is a relevant risk factor for hip
fractures [26,27]. In fact, 50% of women presenting hip
osteoporotic fractures in the United States had serum
vitamin D values lower than 12 ng/ml (30 nmol/L) [28].
Similar results were found among different populations
which suggested that vitamin D serum concentrations could
constitute a useful predictor of hip fracture risk in the
elderly [29-31].
In contrast to our study, other authors evaluating the in-
cidence of VFs observed no significant association with
vitamin D insufficiency [32]. However, the authors failed
to exclude women who had a history of VFs from the con-
trol group, which detracts from a definitive conclusion. A
population-based cohort study by Garnero et al. [33].
showed that serum 25(OH)D was not associated with inci-
dent fracture in postmenopausal French women (mean
age 62.2 years). Roddam et al. [34]., using a nested case–
control design, showed no such association in a British
study population (mean age 52.6 years). However, the
mean age of the participants in these studies was low, and
for younger patients vitamin D status may play a less im-
portant role in fracture risk. A study targeting postmeno-
pausal Japanese-American women living in Hawaii who
had high 25(OH)D concentrations (mean value, 32 ng/ml)
showed no association between vitamin D status and frac-
ture risk [35]. However, this study evaluated all types of
fracture and relied upon X-ray films of asymptomatic
patients to diagnose vertebral fracture; thus, it cannot be
directly compared to our study.
Age and low BMD are independent risk factors for
prevalent VFs. This evidence lends credence to the new
recommendation by the ISCD that VFA should be utilized
in all women with low BMD. We determined the best
model of logistic-regression was with hip BMD and not
with lumbar spine BMD, which may be due to established
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tive alterations that accompany ageing, such as osteophytes,
and facet joint osteoarthritis and/or extraskeletal
calcification around the lumbar spine may falsely increase
the measurement of BMD at this site.
It is now well demonstrated that prevalent VFs are
associated with an increase in morbidity and mortality.
Moreover, post-menopausal women with severe VFs are
at the highest risk of subsequent vertebral and nonvertebral
fracture [36]. In fact, the severity of a previous fracture was
found to be a better predictor of future nonvertebral frac-
ture risk than BMD. In this context, the finding that low
(<10 ng/mL) 25(OH)D concentrations are associated with
a high prevalence of moderate/severe VFs (30% in our
study) supports the inclusion of this modifiable risk factor
as part of the screening, and the identification of postmeno-
pausal women with a high risk of VFs.
The interpretation of a serum level of 25(OH)D in the
“insufficient” range is challenging for several reasons.
Although there are several ways to measure 25(OH)D
(radioimmunoassays, enzyme-linked assays, and liquid
chromatography with mass spectrometry), the precision
and accuracy of the assays, especially in nonreference
laboratories, remain problematic. In one study, identical
serum samples were provided to 6 different laborator-
ies, and the chemiluminescent assay tended to return
higher values for 25(OH)D [37]. The 25OHD assay used
in our study was the Roche electrochemiluminescence
assay that has now been withdrawn from the market, in
part because it underestimated 25(OH)D levels, espe-
cially at low levels and it only measures 25(OH)D3.
Thus, one can speculate that the 25(OH)D reported
levels are lower than the true levels, which may partly
explain the very high proportion of women with 25
(OH)D< 10 ng/ml. However, none of our patients was
under D2 therapy and a cross-calibration data with an-
other assay (Liaison, Diasorin) in 30 patients showed
high correlation (r = 0.92; p< 0.0001) (data not shown).
Moreover, the same observation of high prevalence of
vitamin D deficiency had been reported in a previous
study where the prevalence of values of 25(OH)D lower
than 15 ng/mL were found in 43% of a series of young
healthy Moroccan women during the summer season
and using the technique of chemiluminescence (Liaison,
Diasorin) [11]. In our study, the prevalence of extremely
low vitamin D status (52%) is indeed quite striking. Symp-
tomatic vitamin D deficiency is still a common problem in
Morocco and cases of rickets and osteomalacia are still
observed. However, the serum concentrations of calcium
and phosphorus in our series were within the reference
range and none of our patients had clinical evidence of
osteomalacia.
Finally, 25(OH)D levels change with the seasons, ex-
posure to sunlight, and dietary intake. For example, innorthern latitudes, serum levels of 25(OH)D decline by
20% from late summer to midwinter, whereas 30 minutes
of full-body exposure to the sun during the summer
rapidly generates vitamin D. Rabat which is located at the
34th latitude is almost sunny through all the summer
season. Cultural habits may be the explanation that limits
sun exposure in many Moroccan women as well as low
vitamin D intake. In our country, food is not supplemen-
ted with vitamin D. Hence, cutaneous synthesis would be
the major source of the vitamin in ambulatory women of
this age group. The influence of clothing style on 25(OH)
D level, has been showed in a previous study where in the
summer season and after a multilinear regression analysis,
wearing a veil was found to be an independent predictor
of hypovitaminosis D [38] and similar conclusions has
been reported in Lebanon [39], Saudi Arabia [40] and Tur-
key [41].
Our study had strengths and limitations. The as-
sessment of fracture was carefully conducted using
standard procedures of acquisition and standard read-
ing of all VFAs. All the morphometric assessments were
made by two experienced investigators after training
sessions and after a previous global visualization. Before
diagnosis of fracture, a non-osteoporotic origin was
considered for each deformity as vertebral deformities
can be due to developmental abnormalities, Scheuermann’s
disease sequelae and degenerative changes. Attention has
been paid to osteoporotic depressions of the central end
plates of the vertebrae, as osteoarthritic changes occur only
on the anterior part of the vertebrae. However, even
though history of trauma was inquired, we cannot exclude
that some subjects did not report remote traumas. The
main limitations lie in the cross-sectional nature of the
study and in the procedures used to select subjects, who
were all volunteers and ambulatory. The Rabat population
may not be adequately representative of the whole
population. However, since the population living in the
area of Rabat is a balanced mixture of the various
regions constitutive of the country, we believe the
impact on prevalence estimate is limited. Another
limitation is the dosage of PTH which could not be
performed in this study. Indeed, in a population like
this, with a so high prevalence of low levels of
vitamin D, we would expect to have a secondary
hyperparathyroidism, which, in turn, contributes to
bone loss.Conclusion
Our study shows that the prevalence of vitamin D insuffi-
ciency is very high in Morocco and that hypovitaminosis
D is an independent risk factor for asymptomatic VFs in
Moroccan postmenopausal women as were advanced age
and densitometric osteoporosis. These findings are
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dosage in the fracture risk evaluation and with the re-
cently released report of the Institute of Medicine,
which recommended that healthy adults take 600 IU
daily to maintain skeletal health [42].
Competing interest
The authors declare that they have no competing interest.
Acknowledgments
The study was founded by grants from the University Mohammed V of Rabat
and Roche Laboratories.
Author details
1Rheumatology Department, Military Hospital Mohammed V, PO Box 1018
Rabat, Morocco. 2Biochemistry Department, Military Hospital Mohammed V,
Rabat, Morocco. 3Statistics Department, Agronomic university Hassan II,
Rabat, Morocco.
Authors’ contribution
AEM designed the study, did the statistical analysis and wrote the paper. ZO
participated in the study design, enrollment of subjects and performed the
biological exams. AM participated in the data collection. AR participated in
the data collection. LA participated in the data collection. AB participated in
the data collection. ST performed the biological exams. MD participated in
the statistical analysis. and IG participated in the study design, enrollment of
subjects and participated in the statistical analysis. All authors read and
approved the final manuscript
Received: 24 November 2011 Accepted: 24 April 2012
Published: 24 April 2012
References
1. Cummings-Vaughn LA, Gammack JK: Falls, osteoporosis, and hip fractures.
Med Clin North Am 2011, 95:495–506.
2. Rosen CJ: Clinical practice. Vitamin D insufficiency. N Engl J Med 2011,
364:248–54.
3. Thacher TD, Clarke BL: Vitamin D insufficiency. Mayo Clin Proc 2011, 86:50–60.
4. Mithal A, Wahl DA, Bonjour JP, et al: Global vitamin D status and
determinants of hypovitaminosis D. Osteoporos Int 2009, 20:1807–20.
5. Zadshir A, Tareen N, Pan D, Norris K, Martins D: The prevalence of
hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis
2005, 15:S5–101.
6. van der Meer IM, Middelkoop BJ, Boeke AJ, Lips P: Prevalence of vitamin D
deficiency among Turkish, Moroccan, Indian and sub-Sahara African
populations in Europe and their countries of origin: an overview.
OsteoporosInt 2011, 22:1009–1021.
7. Ramakrishnan S, Bhansali A, Bhadada SK, et al: Vitamin D status and its
seasonal variability in healthy young adults in an asian Indian urban
population. EndocrPract 2011, 17:185–191.
8. Kaykhaei MA, Hashemi M, Narouie B, et al: High prevalence of vitamin d
deficiency in zahedan, southeast iran. Ann Nutr Metab 2011, 58:37–41.
9. Saadi HF, Nagelkerke N, Benedict S, et al: Predictors and relationships of
serum 25 hydroxyvitamin D concentration with bone turnover markers,
bone mineral density, and vitamin D receptor genotype in Emirati
women. Bone 2006, 39:1136–43.
10. Ardawi MS, Qari MH, Rouzi AA, Maimani AA, Raddadi RM: Vitamin D status
in relation to obesity, bone mineral density, bone turnover markers and
vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal
women. Osteoporos Int 2011, 22:463–475.
11. Allali F, El Aichaoui S, Khazani H, et al: High prevalence of hypovitaminosis
D in Morocco: relationship to lifestyle, physical performance, bone markers,
and bone mineral density. Semin Arthritis Rheum 2009, 38:444–451.
12. Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O: Prevalent
vertebral deformities predict increased mortality and increased fracture
rate in both men and women: a 10-year population-based study of 598
individuals from the Swedish cohort in the European Vertebral
Osteoporosis Study. Osteoporos Int 2003, 14:61–8.13. Puisto V, Heliovaara M, Impivaara O, et al: Severity of vertebral fracture and
risk of hip fracture: a nested case–control study. Osteoporos Int 2011,
22:63–68.
14. Jalava T, Sarna S, Pylkkanen L, et al: Association between vertebral fracture
and increased mortality in osteoporotic patients. J Bone Miner Res 2003,
18:1254–60.
15. Trone DW, Kritz-Silverstein D, von Muhlen DG, Wingard DL, Barrett-Connor E:
Is radiographic vertebral fracture a risk factor for mortality? Am J
Epidemiol 2007, 166:1191–7.
16. El Maghraoui A, Morjane F, Nouijai A, Achemlal L, Bezza A, Ghozlani I:
Vertebral fracture assessment in Moroccan women: prevalence and risk
factors. Maturitas 2009, 62:171–175.
17. El Maghraoui A, Mounach A, Gassim S, Ghazi M. Vertebral fracture
assessment in healthy men: prevalence and risk factors. Bone 2008;43:544–8.
18. McCloskey EV, Vasireddy S, Threlkeld J, et al: Vertebral fracture assessment
(VFA) with a densitometer predicts future fractures in elderly women
unselected for osteoporosis. J Bone Miner Res 2008, 23:1561–8.
19. El Maghraoui A, Roux C: DXA scanning in clinical practice. QJM 2008,
101:605–617.
20. El Maghraoui A, Achemlal L, Bezza A: Monitoring of dual-energy X-ray
absorptiometry measurement in clinical practice. J Clin Densitom 2006,
9:281–286.
21. El Maghraoui A, Do Santos Zounon AA, Jroundi I, et al: Reproducibility of
bone mineral density measurements using dual X-ray absorptiometry in
daily clinical practice. Osteoporos Int 2005, 16:1742–1748.
22. Genant HK, Wu CY, van Kuijk C, Nevitt MC: Vertebral fracture assessment
using a semiquantitative technique. J Bone Miner Res 1993, 8:1137–48.
23. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K: Association between
25-hydroxy vitamin D levels, physical activity, muscle strength and
fractures in the prospective population-based OPRA Study of Elderly
Women. Osteoporos Int 2005, 16:1425–31.
24. Delmas PD, van de Langerijt L, Watts NB, et al: Underdiagnosis of vertebral
fractures is a worldwide problem: the IMPACT study. J Bone Miner Res
2005, 20:557–63.
25. Lopes JB, Danilevicius CF, Takayama L, et al: Vitamin D insufficiency: a risk
factor to vertebral fractures in community-dwelling elderly women.
Maturitas 2009, 64:218–22.
26. Sakuma M, Endo N, Oinuma T, et al: Vitamin D and intact PTH status in
patients with hip fracture. Osteoporos Int 2006, 17:1608–14.
27. Bischoff-Ferrari HA, Can U, Staehelin HB, et al: Severe vitamin D deficiency
in Swiss hip fracture patients. Bone 2008, 42:597–602.
28. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J: Occult
vitamin D deficiency in postmenopausal US women with acute hip
fracture. JAMA 1999, 281:1505–11.
29. Moniz C, Dew T, Dixon T: Prevalence of vitamin D inadequacy in
osteoporotic hip fracture patients in London. Curr Med Res Opin 2005,
21:1891–4.
30. Sakuma M, Endo N, Oinuma T: Serum 25-OHD insufficiency as a risk factor
for hip fracture. J Bone Miner Metab 2007, 25:147–50.
31. Lai JK, Lucas RM, Clements MS, Roddam AW, Banks E: Hip fracture risk in relation
to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a
systematic review and meta-analysis of randomised controlled trials and
observational studies. BMC Public Health 2010, 10:331.
32. Cummings SR, Browner WS, Bauer D, et al: Endogenous hormones and the
risk of hip and vertebral fractures among older women. Study of
Osteoporotic Fractures Research Group. N Engl J Med 1998, 339:733–8.
33. Garnero P, Munoz F, Sornay-Rendu E, Delmas PD: Associations of vitamin D
status with bone mineral density, bone turnover, bone loss and fracture
risk in healthy postmenopausal women. The OFELY study. Bone 2007,
40:716–22.
34. Roddam AW, Neale R, Appleby P, Allen NE, Tipper S, Key TJ: Association
between plasma 25-hydroxyvitamin D levels and fracture risk: the
EPIC-Oxford study. Am J Epidemiol 2007, 166:1327–36.
35. Pramyothin P, Techasurungkul S, Lin J, et al: Vitamin D status and falls,
frailty, and fractures among postmenopausal Japanese women living in
Hawaii. Osteoporos Int 2009, 20:1955–62.
36. Pongchaiyakul C, Nguyen ND, Jones G, Center JR, Eisman JA, Nguyen TV:
Asymptomatic vertebral deformity as a major risk factor for subsequent
fractures and mortality: a long-term prospective study. J Bone Miner Res
2005, 20:1349–55.
37. Binkley N, Krueger D, Gemar D, Drezner MK: Correlation among
25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 2008, 93:1804–8.
El Maghraoui et al. BMC Women's Health 2012, 12:11 Page 8 of 8
http://www.biomedcentral.com/1472-6874/12/1138. Allali F, El Aichaoui S, Saoud B, Maaroufi H, Abouqal R, Hajjaj-Hassouni N:
The impact of clothing style on bone mineral density among post
menopausal women in Morocco: a case–control study. BMC Public Health
2006, 6:135.
39. Gannage-Yared MH, Chemali R, Yaacoub N, Halaby G: Hypovitaminosis D in
a sunny country: relation to lifestyle and bone markers. J Bone Miner Res
2000, 15:1856–62.
40. Ghannam NN, Hammami MM, Bakheet SM, Khan BA: Bone mineral density
of the spine and femur in healthy Saudi females: relation to vitamin D
status, pregnancy, and lactation. Calcif Tissue Int 1999, 65:23–8.
41. Guzel R, Kozanoglu E, Guler-Uysal F, Soyupak S, Sarpel T: Vitamin D status
and bone mineral density of veiled and unveiled Turkish women.
J Womens Health Gend Based Med 2001, 10:765–70.
42. Ross AC, Manson JE, Abrams SA, et al: The 2011 report on dietary
reference intakes for calcium and vitamin D from the Institute of
Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011,
96:53–8.
doi:10.1186/1472-6874-12-11
Cite this article as: El Maghraoui et al.: Hypovitaminosis D and prevalent
asymptomatic vertebral fractures in Moroccan postmenopausal women.
BMC Women's Health 2012 12:11.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
